Bridge To Adulthood, Llc | |
5345 Russellville Rd Allensville KY 42204-9024 | |
(270) 987-4456 | |
(888) 270-7319 |
Full Name | Bridge To Adulthood, Llc |
---|---|
Speciality | Counselor - Mental Health |
Location | 5345 Russellville Rd, Allensville, Kentucky |
Authorized Official Name and Position | Brian Comley (PROGRAM DIRECTOR) |
Authorized Official Contact | 2709874456 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Bridge To Adulthood, Llc 5345 Russellville Rd Allensville KY 42204-9024 Ph: (270) 987-4456 | Bridge To Adulthood, Llc 5345 Russellville Rd Allensville KY 42204-9024 Ph: (270) 987-4456 |
NPI Number | 1356839187 |
---|---|
Provider Enumeration Date | 04/26/2018 |
Last Update Date | 04/23/2020 |
Certification Date | 04/23/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1356839187 | NPI | - | NPPES |
7100496400 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
1041C0700X | Social Worker - Clinical | 253242 (Kentucky) | Secondary |
News Archive
A new prosthesis for a traditional ear surgery is bringing hope to patients diagnosed with a hereditary disorder that causes hearing loss. After 63-year-old Diane Duncan was diagnosed with otosclerosis in her thirties, she transitioned into an isolated world where conversations with other people became limited, everyday noises like car engines running and cell phones ringing became almost inaudible.
Research in monkeys suggests that long-term use of estrogen therapy may reduce levels of androgens – hormones involved in maintaining bone density, muscle mass, sexual function, memory, and psychological wellbeing in postmenopausal women.
ARIAD Pharmaceuticals, Inc. today announced that updated clinical data from a fully enrolled Phase 1 trial of its investigational, pan-BCR-ABL inhibitor, ponatinib, will be presented at the 52nd Annual Meeting of the American Society of Hematology being held in Orlando, Florida, December 4-7, 2010.
In a fascinating new medRxiv preprint paper, researchers from the University of Nevada, Reno demonstrate the power of cobalt-functionalized titanium dioxide nanotubes by selectively detecting the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in less than 30 seconds.
› Verified 1 days ago